structure glp 1 Human GLP-1 receptor transmembrane domain in complex with allosteric modulators RCSB PDB - 5VEX: Structure

Higher is not always better: 9 mg often delivers a better efficacy-to-tolerability ratio than 12 mg

The concentration difference is not marginal

WADA Prohibition The World Anti-Doping Agency classification for these peptides: GLP3 likely classified under prohibited substances as a GLP-1 receptor agonist Cagrilintide status as amylin analog may fall under peptide hormone prohibitions Combined formulation would be prohibited under multiple substance categories No Therapeutic Use Exemptions (TUEs) available for either component Detection methods under development for anti-doping testing WADAs position reflects that these remain investigational agents without regulatory approval from health authorities worldwide

Your bodys antioxidant network is already pretty impressive on its own